EYE CARE OF BELFAST LIMITED

Company Registration Number:
NI019042 (Northern Ireland)

Unaudited abridged accounts for the year ended 30 April 2023

Period of accounts

Start date: 01 May 2022

End date: 30 April 2023

EYE CARE OF BELFAST LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2023

Balance sheet
Notes

EYE CARE OF BELFAST LIMITED

Balance sheet

As at 30 April 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 8,711 9,800
Tangible assets: 4 27,445 32,904
Investments: 5 60,000 60,000
Total fixed assets: 96,156 102,704
Current assets
Stocks: 36,909 27,107
Debtors:   194,058 181,895
Cash at bank and in hand: 13,960 10,157
Total current assets: 244,927 219,159
Creditors: amounts falling due within one year:   (174,403) (193,079)
Net current assets (liabilities): 70,524 26,080
Total assets less current liabilities: 166,680 128,784
Creditors: amounts falling due after more than one year:   (36,081) (41,161)
Provision for liabilities: (5,215) 0
Total net assets (liabilities): 125,384 87,623
Capital and reserves
Called up share capital: 10,000 10,000
Profit and loss account: 115,384 77,623
Shareholders funds: 125,384 87,623

The notes form part of these financial statements

EYE CARE OF BELFAST LIMITED

Balance sheet statements

For the year ending 30 April 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 19 January 2024
and signed on behalf of the board by:

Name: Christopher Mackey
Status: Director

The notes form part of these financial statements

EYE CARE OF BELFAST LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

EYE CARE OF BELFAST LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2023

2. Employees

2023 2022
Average number of employees during the period 12 10

EYE CARE OF BELFAST LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2023

3. Intangible Assets

Total
Cost £
At 01 May 2022 10,889
At 30 April 2023 10,889
Amortisation
At 01 May 2022 1,089
Charge for year 1,089
At 30 April 2023 2,178
Net book value
At 30 April 2023 8,711
At 30 April 2022 9,800

EYE CARE OF BELFAST LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2023

4. Tangible Assets

Total
Cost £
At 01 May 2022 246,340
Additions 2,168
At 30 April 2023 248,508
Depreciation
At 01 May 2022 213,436
Charge for year 7,627
At 30 April 2023 221,063
Net book value
At 30 April 2023 27,445
At 30 April 2022 32,904

EYE CARE OF BELFAST LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2023

5. Fixed investments

Investments in subsidiary undertakings are recognised at cost.